The pre-mRNA splicing factor U2AF (U2 snRNP auxiliary factor) has an essential role in 3 splice site selection. U2AF binds the intron pyrimidine tract between the branchpoint and the 3 splice site and recruits U2 snRNP to the branch site at an early step in spliceosome assembly. Human U2AF is a heterodimer composed of large (hU2AF The generation of functional mRNAs in eukaryotes requires the accurate removal of noncoding sequences (introns) from pre-mRNAs by a process termed pre-mRNA splicing (Moore et al. 1993; Sharp 1994; Kramer 1996) . Pre-mRNA splicing takes place in the spliceosome, a dynamic RNA-protein complex composed of small nuclear ribonucleoprotein particles (snRNPs) and extrinsic (nonsnRNP) protein factors. The earliest steps in spliceosome assembly involve recognition of the 5Ј splice site by U1 snRNP and the branchpoint-3Ј splice site by U2 snRNP. Targeting of U2 snRNP to the branch site requires the extrinsic splicing factor U2AF (U2 snRNP auxiliary factor) (Ruskin et al. 1988) . U2AF binds specifically to the intron pyrimidine tract located between the branchpoint and the 3Ј splice site and recruits U2 snRNP to the branch site at an early step in spliceosome assembly (Ruskin et al. 1988; Zamore et al. 1992; Staknis and Reed 1994) . Regulation of 3Ј splice site choice, both positive and negative, can be realized by influencing the pyrimidine tract binding of U2AF (Tian and Maniatis 1993; Valcá rcel et al. 1993; Reed 1996) .
The generation of functional mRNAs in eukaryotes requires the accurate removal of noncoding sequences (introns) from pre-mRNAs by a process termed pre-mRNA splicing (Moore et al. 1993; Sharp 1994; Kramer 1996) . Pre-mRNA splicing takes place in the spliceosome, a dynamic RNA-protein complex composed of small nuclear ribonucleoprotein particles (snRNPs) and extrinsic (nonsnRNP) protein factors. The earliest steps in spliceosome assembly involve recognition of the 5Ј splice site by U1 snRNP and the branchpoint-3Ј splice site by U2 snRNP. Targeting of U2 snRNP to the branch site requires the extrinsic splicing factor U2AF (U2 snRNP auxiliary factor) (Ruskin et al. 1988) . U2AF binds specifically to the intron pyrimidine tract located between the branchpoint and the 3Ј splice site and recruits U2 snRNP to the branch site at an early step in spliceosome assembly (Ruskin et al. 1988; Zamore et al. 1992; Staknis and Reed 1994) . Regulation of 3Ј splice site choice, both positive and negative, can be realized by influencing the pyrimidine tract binding of U2AF (Tian and Maniatis 1993; Valcá rcel et al. 1993; Reed 1996) .
Human U2AF is a heterodimer composed of a 65-kD large subunit (hU2AF 65 ) and a 35-kD small subunit (hU2AF 35 ) (Zamore and Green 1989) . Both subunits are highly conserved across species (Zamore and Green 1991) ; U2AF homologs have been identified in Drosophila melanogaster (Kanaar et al. 1993; Rudner et al. 1996) , Schizosaccharomyces pombe (Potashkin et al. 1993; Wentz-Hunter and Potashkin 1996) , and Caenorhabditis elegans (Zorio et al. 1997; T. Blumenthal, pers. comm.) . The Drosophila U2AF large (dU2AF
50
) and small (dU2AF
38
) subunit homologs are 50 and 38 kD, respectively (Kanaar et al. 1993; Rudner et al. 1996) . The large subunit contains three RNA recognition motifs (RRMs) and an amino-terminal arginine-serine-rich (RS) domain . The small subunit contains a highly degenerate (pseudo-) RRM (Birney et al. 1993) , two putative Zn 2+ binding motifs (Worthington et al. 1996) , and a carboxy-terminal RS domain and glycinerich region (Zhang et al. 1992) .
Biochemical studies of U2AF using extracts depleted of U2AF activity lead to some confusion as to the requirement for the large and small subunits in splicing. Depending on the substrate used and method of U2AF depletion (poly(U)-sepharose or immunoaffinity chromatography), different requirements for the large or large and small subunits were observed (Zamore and Green 1991; Zamore et al. 1992; Kanaar et al. 1993; Valcá rcel et al. 1996; Zuo and Maniatis 1996; Gama-Carvalho et al. 1997) . Both Drosophila U2AF subunits are required for viability suggesting that both subunits are necessary for splicing in vivo (Kanaar et al. 1993; Rudner et al. 1996) .
Although both U2AF subunits contain RS domains, these domains have been assigned independent roles in spliceosome assembly. Consistent with a direct role in U2 snRNP recruitment, deletion of the RS domain from hU2AF 65 (hU2AF 65 ⌬RS) had no effect on pyrimidine tract binding yet it completely abolished the ability to restore splicing to U2AF-depleted extracts Valcá rcel et al. 1996 ⌬RS was sufficient to restore splicing activity (Valcá rcel et al. 1996) . Based on the sole requirement for a net positive charge, it was proposed that the essential role of the hU2AF 65 RS domain is to facilitate annealing of the U2 snRNA and the branch site sequence through charge shielding of the RNA phosophodiester backbones (Valcá rcel et al. 1996) .
Whereas the large subunit RS domain is thought to promote RNA-RNA interactions in U2 snRNP recruitment, the small U2AF subunit RS domain has been implicated in protein-protein interactions with constitutive and alternative splicing factors that serve to stabilize binding of hU2AF 65 to intron pyrimidine tracts. A role for the small subunit in bridging constitutive and alternative splicing factors and hU2AF 65 was first suggested by protein-protein interaction studies (Wu and Maniatis 1993; Amrein et al. 1994 ). These studies revealed that hU2AF 35 , but not hU2AF 65 , specifically interacts with the SR family of general splicing factors as well as the Drosophila alternative splicing factors transformer (TRA) and transformer2 (TRA2).
The SR proteins are a family of conserved splicing factors with similar domain structure and partially overlapping biochemical activities (Fu 1995; Manley and Tacke 1996) . SR proteins contain at least one RRM-type RNAbinding domain and a serine-arginine-rich (SR or RS) domain that has been implicated in protein-protein interactions in vitro (Wu and Maniatis 1993; Amrein et al. 1994; Kohtz et al. 1994; Xiao and Manley 1997) . In vivo, the Drosophila SRp55/B52 gene and the mammalian ASF/SF2 gene, including its RS domain, are essential for viability (Ring and Lis 1994; Wang et al. 1996) . SR proteins are required at an early stage in mammalian spliceosome assembly and can promote U1 snRNP and U2AF binding to pre-mRNA in the earliest known mammalian spliceosomal complex (E complex) (Staknis and Reed 1994) . In fact, SR proteins can simultaneously interact with both the U1 snRNP 70-kD protein, U1-70K, and with hU2AF 35 in the yeast two-hybrid assay (Wu and Maniatis 1993) . The RS domain on both U1-70K and hU2AF 35 have been implicated in these protein-protein interactions (Wu and Maniatis 1993; Kohtz et al. 1994) .
SR proteins also bind exonic enhancer elements located downstream from weak 3Ј splice sites (Lavigueur et al. 1993; Sun et al. 1993; Wang et al. 1995; Tacke et al. 1997) . Addition of SR proteins to nuclear extract promotes U2AF binding to pre-mRNA substrates containing these enhancer elements. Consistent with a role for hU2AF 35 in bridging SR proteins bound to enhancers and hU2AF 65 bound to weak pyrimidine tracts, reconstitution of enhancer-dependent splicing in U2AF-depleted extracts requires the addition of recombinant hU2AF 35 (Zuo and Maniatis 1996) . Addition of hU2AF 35 lacking its RS domain (hU2AF 35 ⌬RS) is insufficient for enhancer-dependent splicing, further implicating the RS domain in these critical protein-protein interactions (Zuo and Maniatis 1996) .
One of the best characterized examples of enhancerdependent splicing involves the sex-specific, alternative splicing of doublesex (dsx) in the sex determination pathway in Drosophila. The alternative splicing factors TRA and TRA2 are required for the female-specific, alternative splicing of dsx (Baker and Wolfner 1988; Cline and Meyer 1996) . TRA and TRA2 activate a weak, female-specific, 3Ј splice site in the dsx pre-mRNA. The resulting mRNA encodes a DSX isoform required for somatic female differentiation. TRA2 has an RRM and both TRA and TRA2 have RS domains. The RS domains on TRA and TRA2 have been implicated in protein-protein interactions with SR proteins and hU2AF
35 (Wu and Maniatis 1993; Amrein et al. 1994) . Biochemical analysis of the alternative splicing of dsx has revealed that TRA and TRA2 bind to exonic enhancer elements downstream of the regulated dsx intron and recruit SR proteins to form a splicing enhancer complex (Hedley and Maniatis 1991; Tian and Maniatis 1993) . This complex promotes U2AF binding to the weak pyrimidine tract of the female-specific 3Ј splice site (Zuo and Maniatis 1996) . Reconstitution of female-specific dsx splicing requires both U2AF subunits as well as TRA and TRA2.
We have undertaken a molecular genetic analysis of the Drosophila U2AF homolog in vivo. (Rudner et al. 1998) . All three of these critical residues were deleted in dU2AF 50 ⌬RS extreme and dU2AF 50 (RS) 7extreme ( Fig. 2A ) as well as in the analogous hU2AF 65 mutant proteins (Valcá rcel et al. 1996) . Because the poly(U)-depleted extract does not require the small subunit for reactivation , deletion of these conserved residues in hU2AF 65 would not affect its activity in vitro. The requirement for heterodimer formation in vivo, however, complicates our molecular genetic analysis. We conclude that the inability of the dU2AF 50 ''extreme'' derivatives to complement the dU2AF 50 recessive lethal allele does not address the requirement for the remaining positively charged residues in dU2AF 50 ⌬RS true , but it does support the conclusion drawn from our previous study. Consistent with a requirement for both U2AF subunits for splicing in vitro, heterodimer formation is essential in vivo (Rudner et al. 1998) .
To address the requirement for the remaining positively charged residues in dU2AF 50 ⌬RS true , a final set of dU2AF 50 mutant transgenes were created. The three positively charged residues remaining at the amino terminus in the dU2AF 50 ⌬RS true transgene were deleted to create dU2AF 50 ⌬RS final ( Fig. 2A) . A synthetic RS domain was fused to this final deletion mutant to create Fig. 2A) . In contrast to the requirement for positive charges in the large subunit RS domain in vitro, the positively charged residues were not necessary in vivo. We conclude that the Drosophila U2AF large subunit RS domain is completely dispensable. These results indicate that the dU2AF 50 RS domain is not required for U2 snRNP recruitment during spliceosome assembly in vivo.
The dU2AF 38 RS domain and glycine-rich carboxyl terminus are dispensable in vivo
The lack of requirement for the dU2AF 50 RS domain in vivo, prompted an analysis of the dU2AF 38 RS domain. We have shown previously that a recessive lethal deletion mutation that disrupts the Drosophila U2AF small subunit gene can be rescued by a transgene containing a genomic clone that includes the gene encoding dU2AF 38 (Rudner et al. 1996) 35 RS domain has glycine-rich regions interdigitated with the RS dipeptide repeats, whereas the glycine-rich regions of dU2AF 38 are distinct from its RS domain ( Fig. 3B) (Rudner et al. 1996) . To determine the in vivo requirement for the glycine-rich carboxyl terminus of dU2AF 38 , a stop codon was introduced at amino acid 216 in the dU2AF 38 -coding sequence in the rescuing genomic transgene to create dU2AF 38 ⌬Gly. This nonsense mutation eliminates the entire glycine-rich carboxyl terminus but leaves the RS domain intact (Fig. 3B) . Germline transformants containing the dU2AF 38 ⌬Gly transgene were generated and tested for complementation of the dU2AF 38 recessive lethal deletion mutation. The dU2AF 38 ⌬Gly transgene efficiently rescued the dU2AF 38 null allele (Fig. 3A) . The ability of the dU2AF 38 ⌬Gly transgene to rescue was not attributable to translational readthrough of the engineered stop codon as only dU2AF 38 protein, of a size consistent with the deletion of the glycine-rich region, was detected by immunoblot analysis of whole-fly extracts from dU2AF 38 ⌬Gly-rescued flies (Fig. 4, cf. lanes 1, 2, and 3) . Overexposure of the immunoblot or overloading the whole-fly extract failed to reveal any wild-type, fulllength, dU2AF 38 protein (data not shown). Therefore, this glycine-rich region including the carboxy-terminal run of 11 consecutive glycines, though rather distinctive and conserved from Drosophila to mammals, is not essential in vivo.
To (Fig. 3A) . We conclude that the U2AF small subunit RS domain is not required in vivo.
Because the glycine-rich regions are interdigitated with the RS dipeptide repeats in the hU2AF 35 RS domain, the hU2AF 35 RS deletion mutant used in the in vitro reconstitution experiments lacked both the RS domain and glycine-rich regions (Fig. 3B ) (Zuo and Maniatis 1996) . This deletion mutant was incapable of restoring enhancer-dependent splicing to the immunodepleted extracts. In an attempt to directly correlate our in vivo complementation data with the results of the in vitro reconstitution experiments, we inserted a stop codon at amino acid 189 in the dU2AF 38 -coding sequence of the rescuing genomic transgene to create dU2AF 38 ⌬RSGly (Fig. 3B) . This nonsense mutation eliminates the RS domain and glycine-rich carboxyl terminus of dU2AF 38 and is a more extensive deletion than the hU2AF 35 RS deletion used in vitro (Fig. 3B) . Germ-line transformants con- ⌬RS mutant used in the in vitro reconstitution experiments (Zuo and Maniatis 1996). taining the dU2AF 38 ⌬RSGly transgene were generated and tested for complementation of the dU2AF 38 recessive lethal deletion mutation. Surprisingly, the dU2AF 38 ⌬RSGly transgene also completely rescued the dU2AF 38 null allele (Fig. 3A) . In contrast to the requirement for the hU2AF 35 RS domain for splicing in vitro, the dU2AF 38 RS domain and glycine-rich region were completely dispensable in vivo. The ability of the dU2AF 38 ⌬RSGly transgene to complement the dU2AF 38 null mutant is not a consequence of translational readthrough of the engineered stop codon, as the dU2AF 38 deletion mutant was the only protein detected by immunoblot analysis of a whole-fly extract from the rescued flies (Fig. 4, cf. lanes 1, 2, and 5) .
Although the human and Drosophila small subunit RS domains differ in the placement of the glycine-rich regions, the overall sequence similarity (Fig. 3B) suggests that the lack of requirement for the small subunit RS domain in vivo is not specific to Drosophila. In fact, the recent identification of the U2AF small subunit homolog from S. pombe (pU2AF 23 ) reveals substantial amino acid conservation in the amino terminus (77%) but the complete absence of a carboxy-terminal RS domain (WentzHunter and Potashkin 1996) . We conclude that the essential function of the U2AF small subunit does not reside in the RS domain and is therefore not necessary for constitutive splicing in vivo.
The dU2AF 38 RS domain is not required for enhancer-dependent splicing of doublesex in vivo
If the dU2AF 38 RS domain is required for enhancer-dependent, female-specific splicing of the dsx pre-mRNA, then female flies lacking the dU2AF 38 RS domain (dU2AF
38
⌬RS or dU2AF 38 ⌬RSGly) should be incapable of efficient female-specific dsx splicing. Inefficient female-specific splicing of dsx would cause partial or complete sexual transformation of female flies, a phenotype observed in TRA or TRA2 mutant females (Nagoshi et al. 1988; Nagoshi and Baker 1990) . Dimorphic body parts on the diplo X, homozygous dU2AF 38 mutant flies carrying the dU2AF 38 ⌬RS or dU2AF 38 ⌬RSGly transgenes were analyzed for sexual transformation. The rescued flies were phenotypically female and fully fertile (data not shown). Therefore, in contrast to previous biochemical studies using human splicing extracts and human U2AF
35 (Zuo and Maniatis 1996) , the dU2AF 38 RS domain is not required for enhancer-dependent alternative splicing of dsx in vivo. These results are consistent with previous genetic analysis of a semi-lethal (hypomorphic) allele of dU2AF 38 (Rudner et al. 1996) . In these studies, no genetic interactions were observed between TRA, TRA2, and the dU2AF 38 hypomorphic mutation. To confirm that the splicing of dsx RNA is unaffected in the flies lacking the dU2AF 38 RS domain, we analyzed dsx transcripts molecularly. Total RNA from w 1118 (dU2AF
38+
) and dU2AF 38 mutant flies carrying the dU2AF 38 ⌬RSGly transgene was isolated. dsx splicing was analyzed by reverse-transcription PCR (RT-PCR) using primers specific for male and female dsx transcripts (Fig. 5B) (Amrein et al. 1994) . No products were observed in the absence of reverse transcription (Fig. 5A, lanes  1,3,5,7) . As expected, only male-specific dsx mRNA was observed in wild-type and dU2AF 38 ⌬RSGly mutant males (Fig. 5A, lanes 2,6) . Consistent with our phenotypic analysis of the dU2AF 38 ⌬RSGly mutants, only female-specific dsx mRNA was observed in both wild-type and dU2AF 38 ⌬RSGly mutant females (Fig. 5A, lanes  4,8) . Therefore, in the absence of the dU2AF 38 RS domain, dsx splicing enhancer function is normal. (Fig. 6 ; see Materials and Methods). We conclude that the presence of at least one RS domain on U2AF is required for viability.
An RS domain is necessary on the U2AF heterodimer

A synthetic RS domain is not sufficient for U2AF activity in vivo
Deletion of the small subunit RS domain provided a genetic background in which to investigate the functional ⌬RS will restore splicing activity in vitro (Valcá rcel et al. 1996) , it did not rescue the double mutant in vivo (Fig. 6) . We conclude that, in vivo, a simple RS dipeptide repeat is not equivalent to a U2AF RS domain.
Discussion
The results presented here demonstrate that the dU2AF 50 RS domain and the dU2AF 38 RS domain are completely dispensable in vivo. Although neither U2AF RS domain is required in vivo, we have found that at least one must be present on the U2AF heterodimer for biological activity. Finally, we have shown that a synthetic RS domain containing seven RS dipeptides is not equivalent to a U2AF RS domain.
The U2AF large subunit RS domain is dispensable in vivo
In contrast to the requirement for the hU2AF 65 RS domain for U2 snRNP recruitment in vitro, our molecular genetic analysis indicates that this domain is not necessary for splicing in vivo. Resolution of these contradictory results is suggested by the synthetic lethality resulting from deletion of both U2AF RS domains. The requirement for at least one RS domain on U2AF indicates that the two domains might be functionally redundant. ⌬RS was sufficient to restore splicing activity to the poly(U)-depleted extracts (Valcá rcel et al. 1996) . This result indicates that the hU2AF 35 RS domain is capable of U2 snRNP recruitment in vitro.
The results of our genetic assays demonstrate that a synthetic RS domain containing seven RS dipeptides is insufficient for U2AF activity in vivo indicating that a simple RS dipeptide repeat is not equivalent to a U2AF RS domain. Because this identical synthetic RS domain was sufficient for U2 snRNP recruitment in vitro (Valcá rcel et al. 1996) , it is possible that the synthetic RS domain is not sufficient for interaction with other splicing factors as might be required in vivo (see below). It is also possible there is a species-specific mechanistic difference between the Drosophila and human U2AF proteins.
The U2AF small subunit RS domain is dispensable for constitutive and dsx enhancer-dependent splicing in vivo
Although the biochemical analysis of hU2AF 65 is consistent with functionally redundant RS domains, the ex- periments involving hU2AF 35 are not. The protein-protein interaction studies that identified specific interactions between hU2AF
35 and the constitutive and alternative splicing factors did not detect interactions between these splicing factors and hU2AF 65 (Wu and Maniatis 1993) . In these experiments, hU2AF
65 was used as a negative control. The inability of hU2AF 65 to interact with these splicing factors appears to be inconsistent with the U2AF RS domains having redundant functions.
The domain on hU2AF 35 required for interaction with these splicing factors was found to include the hU2AF 35 RS domain, but this interaction domain was not thoroughly mapped and might also require another part of hU2AF 35 protein (Wu and Maniatis 1993) . By analogy, it was shown recently that the RS domain on SRp30a (ASF/ SF2) is not sufficient for interaction with the U1 snRNP specific protein U1-70K (Xiao and Manley 1997 Alternatively, it is possible that the protein-protein interactions between the small subunit and these splicing factors that have been observed in vitro and in the yeast two-hybrid assay are not relevant in vivo. Recently, a transgene containing the Drosophila U1 snRNP 70-kD (dU1-70K) gene lacking its RS domain was found to rescue a recessive lethal mutation in dU1-70K (S. Mount, pers. comm.) . This result indicates that the U1-70K RS domain is also inessential in vivo and suggests that the protein-protein interactions observed between U1-70K and SR proteins in vitro are also not necessary for spliceosome assembly in vivo. Recent studies have shown, however, that the mammalian SR protein ASF/ SF2 requires its RS domain for viability in vivo (Wang et al. 1996) . Interestingly, the Saccharomyces cerevisiae U1-70K homolog (Smith and Barrell 1991) 
Functional redundancy of U2AF RS domains in vivo
Because the U2AF proteins are complexed in a heterodimer and deletion of both RS domains results in synthetic lethality, it is reasonable to hypothesize that the RS domains are redundant and can functionally substitute for each other. An alternative interpretation of the synthetic lethality, however, is that the independent functions assigned to the two RS domains are both redundant with two other activities, one involved in U2 snRNP recruitment and the other in protein-protein interaction. Each redundant activity could individually support viability in the absence of one RS domain but deletion of both RS domains might be too great a burden for these two redundant activities resulting in the observed synthetic lethality. The (h)U2AF 65 associated protein (UAP56), a human DEAD box protein required for U2 snRNPbranchpoint interaction, could be redundant with the hU2AF 65 RS domain (Fleckner et al. 1997) ; and the novel set of bridging interactions between U1 snRNP and hU2AF 65 suggested by the analysis of the branchpoint bridging protein (BBP) in yeast (Abovich and Rosbash 1997) and the recent identification of a (h)U2AF 35 related protein (URP) in mammals (Tronchè re et al. 1997) , both qualify as potentially redundant with the hU2AF 35 RS domain. Although this model is plausible, it does not account for the essential requirement for the individual U2AF RS domains observed in vitro. We favor the first model in consideration of parsimony.
Although we have detected modest splicing defects in dying dU2AF 50 mutant larvae, it has not been possible to convincingly show that the cause of lethality in Drosophila U2AF subunit mutants is a splicing defect (D.Z. Rudner and D.C. Rio, unpubl.) . This is likely attributable to the fact that the dying mutant larvae slowly run out of the U2AF protein and/or RNA that was maternally deposited in the mutant embryo. In metazoan nuclei, unspliced nuclear pre-mRNA may simply be degraded. In addition, the splicing of certain introns may be more sensitive to the level of U2AF than others, making detection of a defect in splicing nontrivial. Even with tight temperature-sensitive alleles in certain S. cerevisiae splicing factors, it is not always possible to detect a splicing defect in all introns at the nonpermissive temperature. The accumulated biochemical evidence demonstrating an essential requirement for U2AF in constitutive splicing in vitro (Zamore and Green 1991; Zuo and Maniatis 1996; Kanaar et al. 1993 ) and the requirement for the S. pombe U2AF large subunit homolog for splicing in vivo (Potashkin et al. 1993) , however, makes it likely that the cause of death in the U2AF mutants in Drosophila is a defect in splicing. At this point in time, we cannot rule out the formal possibility that U2AF ac- Old and new models for U2AF RS domains. (A) The two U2AF RS domains were originally assigned separate functions in spliceosome assembly. The large subunit (65) RS domain recruits U2 snRNP (U2) to the branch site ''A'' and the small subunit (35) RS domain interacts with the RS domains on constitutive and alternative splicing factors (SR) to stabilize the large subunit binding to the intron pyrimidine tract (py). (B) Both U2AF RS domains participate in all the tasks assigned to U2AF RS domains in the redundant function model. Both RS domains can target U2 snRNP to the branch site and interact with constitutive and alternative splicing factors.
